DCM
TMCI icon

Davis Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Davis Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-250
Closed -$1.68K – 652
2025
Q3 		$1.68K Buy
+250
New +$1.63K ﹤0.01% 308
2025
Q1 		$2.1K Hold
250
– – ﹤0.01% 284
2024
Q4 		$1.86K Hold
250
– – ﹤0.01% 288
2024
Q3 		$1.45K Hold
250
– – ﹤0.01% 311
2024
Q2 		$1.62K Hold
250
– – ﹤0.01% 291
2024
Q1 		$3.13K Hold
250
– – ﹤0.01% 261
2023
Q4 		$3.19K Buy
+250
New +$2.53K ﹤0.01% 263

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Davis Capital Management's TMCI Position: Q4 2025 in Review

Davis Capital Management sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 250 shares — an estimated $1.68K sold.

Davis Capital Management first reported a position in TMCI in Q4 2023 and held it in 7 quarters. The position peaked at $3.19K in Q4 2023. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Davis Capital Management reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • Davis Capital Management sold 250 Treace Medical Concepts shares in Q4 2025, an estimated $1.68K.
  • Davis Capital Management first reported a position in Treace Medical Concepts in Q4 2023 and held it in 7 quarters.
  • Davis Capital Management's Treace Medical Concepts position peaked at $3.19K in Q4 2023.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Davis Capital Management's 13F filing for Q4 2025, filed 28 Jan 2026.